Home

TIMOTHY R G SEAR

CIK 1305432 · last filed 2013-01-03

TIMOTHY R G SEAR is a corporate insider who has filed 51 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider was granted $12.4K of GTXI on Jan 3, 2013. Across all open-market trades the lifetime net is +$1.0M, making them a net buyer over the disclosed history. 2 SEC filings were submitted jointly with NINA FEDOROFF.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

51

Lifetime Open-Market Net

$1.01M

Filer Profile

Reported Address
175 TOYOTA PLAZA
7TH FLOOR
MEMPHIS, TN 38103
Related Filers
NINA FEDOROFF — 2 joint filings, latest 2006-03-31
LEE MCCOLLUM — 2 joint filings, latest 2006-03-31
Avi M Nash — 2 joint filings, latest 2006-03-31
WILLIAM C ONEIL — 2 joint filings, latest 2006-03-31
J PEDRO REINHARD — 2 joint filings, latest 2006-03-31
D DEAN SPATZ — 2 joint filings, latest 2006-03-31
BARRETT A TOAN — 2 joint filings, latest 2006-03-31
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Oncternal Therapeutics, Inc. (GTXI) Delisted Director 2,795 — — $1.01M 42 2013-01-03
SIGMA ALDRICH CORP (SIAL) Delisted Director 42,000 — — $0 9 2010-01-11

Recent Filings

51 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2013-01-03 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +2,946 $12.4K EDGAR
2012-12-19 Oncternal Therapeutics, Inc. (GTXI) Delisted — — $0 EDGAR
2012-12-18 Oncternal Therapeutics, Inc. (GTXI) Delisted Buy (P) +50,000 $216.3K EDGAR
2012-10-02 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +1,801 $8.2K EDGAR
2012-07-06 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) — $0 EDGAR
2012-07-03 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +2,556 $9.0K EDGAR
2012-04-03 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +2,727 $10.5K EDGAR
2012-01-04 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +2,455 $8.3K EDGAR
2011-10-04 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) +2,462 $8.3K EDGAR
2011-08-05 Oncternal Therapeutics, Inc. (GTXI) Delisted Buy (P) +30,000 $110.2K EDGAR
Showing 1–10 of 51
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.